(Applicant's Description) The Vanderbilt Cancer Center is a comprehensive, multidisciplinary clinical and laboratory research center. The Vanderbilt Cancer Center integrates the cancer-related expertise and resources of the School of Medicine, Vanderbilt University Hospital, and the Vanderbilt Clinic within the Vanderbilt Univer- sity Medical Center; the fully integrated Veterans Administration (VA) Medical Center and the Departments of Chemistry and Molecular Biology in the School of Arts and Sciences. All facilities are located in close proximity on the same campus, a situation which promotes interactions, sharing of resources and collaborations. Established in 1993, the Vanderbilt Cancer Center functions as an organizational unit with a supradepartmental status. The Vanderbilt Cancer Center's specific authorities and responsibilities are: (1) To coordinate and integrate the cancer and cancer-related activities of Vanderbilt University. (2) To conduct, support and enhance cancer research and to integrate cancer-related research throughout the University. (3) To integrate, develop, and conduct cancer education programs. (4) To coordinate and integrate the care of cancer patients at Vanderbilt University Medical Center and the Veterans Administration Medical Center. The research objectives are accomplished through eight research programs and nine shared resources: Programs: (1) Signal Transduction, (2) Regulation of Cell Proliferation, (3) Gastrointestinal Cancer, (4) Cancer Etiology, (5) Cancer Genetics, (6) Breast Cancer, (7) Cancer Pharmacology, (8) Clinical Investigations; Shared Resources: (1) Biostatistics/Data Management, (2) Bioanalytical, (3) Cell Imaging, (4) DNA Sequencing, (5) Genetics, (6) Peptide Sequencing and Amino Acid Analysis, (7) Transgenic Mouse/ES Cell, (8) Human Tissue Acquisition and Pathology, and (9) Viral Vector. Integration of all cancer-related activities under the authority of the Vanderbilt Cancer Center provides an effective administrative structure to promote novel interactive approaches to cancer research, and partial support for this research infrastructure is requested in this application for a Cancer Center Support Grant.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA068485-03S1
Application #
2859161
Study Section
Cancer Centers and Research Programs Review Committee (CCRP)
Program Officer
Bhorjee, Jaswant
Project Start
1998-09-01
Project End
1999-08-31
Budget Start
1998-09-01
Budget End
1999-08-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Gilchuk, Pavlo; Kuzmina, Natalia; Ilinykh, Philipp A et al. (2018) Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein. Immunity 49:363-374.e10
Hebron, Katie E; Li, Elizabeth Y; Arnold Egloff, Shanna A et al. (2018) Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis. Sci Rep 8:3208
Bangaru, Sandhya; Zhang, Heng; Gilchuk, Iuliia M et al. (2018) A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nat Commun 9:2669
Means, Anna L; Freeman, Tanner J; Zhu, Jing et al. (2018) Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer. Cell Mol Gastroenterol Hepatol 6:257-276
Du, Zhenfang; Lovly, Christine M (2018) Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer 17:58
Zhang, Qin; Jeppesen, Dennis K; Higginbotham, James N et al. (2018) Mutant KRAS Exosomes Alter the Metabolic State of Recipient Colonic Epithelial Cells. Cell Mol Gastroenterol Hepatol 5:627-629.e6
Elion, David L; Cook, Rebecca S (2018) Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment. Oncotarget 9:29007-29017
Kook, Seunghyi; Qi, Aidong; Wang, Ping et al. (2018) Gene-edited MLE-15 Cells as a Model for the Hermansky-Pudlak Syndromes. Am J Respir Cell Mol Biol 58:566-574
Choksi, Yash A; Reddy, Vishruth K; Singh, Kshipra et al. (2018) BVES is required for maintenance of colonic epithelial integrity in experimental colitis by modifying intestinal permeability. Mucosal Immunol 11:1363-1374
Cooke, Allison L; Morris, Jamie; Melchior, John T et al. (2018) A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL. J Lipid Res 59:1244-1255

Showing the most recent 10 out of 2462 publications